Bli medlem
Bli medlem

Du är här


RaySearch Laboratories: Netherlands first proton therapy center selects RayStation

RayStation® is set to play a key role in the introduction of proton
therapy in the Netherlands.

RayStation has been selected as the treatment planning solution for
the Holland Particle Therapy Centre (HollandPTC), the first proton
therapy center to be established in the Netherlands. The facility
will open in August 2017 and expects to treat around 600 patients per
year using the Varian ProBeam® System. The new center will mean that
patients in the Netherlands no longer have to travel abroad to
receive proton therapy.

Outstanding capabilities for proton planning, based on proven,
innovative technology, make RayStation the solution of choice for
many of the leading proton therapy centers worldwide. HollandPTC
selected RayStation over other market-leading alternatives following
an extensive tender process. RayStation received the highest
assessment in a number of key areas, including adaptive therapy,
connectivity, automation and scripting, user experience, and plan
optimization. Next-generation plan optimization was an important
area for HollandPTC, and RayStation's multi-criteria optimization
made the system a clear leader.

Delivery of the treatment planning solution will begin in the third
quarter of 2016, with functionality including pencil beam scanning,
adaptive therapy, radiobiology and multi-criteria optimization. The
agreement includes both clinical and research licenses.

As well as supporting world-class patient care, RayStation will play
an important role as a platform for pioneering research. The research
partnership will cover areas such as adaptive therapy (online and
offline), automated multi-criteria optimization, range verification
and radiobiologically guided therapies.

Martijn Eenink, Medical Physicist at HollandPTC and Leiden University
Medical Center, says: "We are excited about the opportunities
RayStation offers for delivering state-of-the-art patient care.
RayStation's multi-criteria optimization will facilitate the
production of treatment plans of the highest quality. The integrated
support for image-guided proton therapy will allow us to easily adapt
these plans to changes in patient anatomy during the course of
treatment, thereby enhancing treatment accuracy."

Johan Löf, CEO of RaySearch Laboratories, says: "Proton therapy is an
important area of focus for RaySearch, and we have designed
RayStation to deliver on its therapeutic possibilities. We have also
ensured that RayStation can be used to create treatment plans for all
relevant proton therapy machines on the market, and this of course
includes the Varian ProBeam. I'm excited about the opportunity to
both support clinical excellence at HollandPTC and drive development
through this partnership."

About proton therapy
Proton therapy is a cutting-edge radiation therapy technique that is
growing in popularity worldwide. Its benefits include the ability to
deliver maximum dose at a very precise depth in the body, with
significantly less irradiation of healthy tissue.

About HollandPTC
HollandPTC is a partnership between Erasmus University Medical Center,
Leiden University Medical Center and the Delft University of
Technology. In addition to patient care, the center will provide
education and conduct an extensive research and development program.

About RayStation
RayStation integrates all RaySearch's advanced treatment planning
solutions into a flexible treatment planning system. It combines
unique features such as multi-criteria optimization tools with full
support for 4D adaptive radiation therapy. It also includes
functionality such as RaySearch's market-leading algorithms for IMRT
and VMAT optimization and highly accurate dose engines for photon,
electron, proton and carbon ion therapy. The system is built on the
latest software architecture and features a graphical user interface
with state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch markets the RayStation treatment planning system to clinics
all over the world. In addition, RaySearch's products are distributed
through licensing agreements with leading medical technology
companies. RaySearch's software is used by over 2,600 clinics in more
than 65 countries. RaySearch was founded in 2000 as a spin-off from
Karolinska Institutet in Stockholm, and the company is listed in the
Mid Cap segment on NASDAQ OMX Stockholm.

To learn more about RaySearch, go to:

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.